Skip to main content

Table 3 Laboratory data and adipose tissue area with computed tomography in patients with T2DM

From: Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus

  Patients with T2DM (N=148)
Laboratory data  
 Creatinine, mg/dl 0.92 ± 0.17
 eGFR, ml/min 83 ± 26
 Triglyceride, mg/dl 139 ± 100
 HDL cholesterol, mg/dl 50 ± 15
 Total cholesterol, mg/dl 198 ± 34
 F-LDL cholesterol, mg/dl 119 ± 32
 Fasting plasma glucose, mg/dl 138 ± 38
 Hemoglobin A1c, % 7.9 ± 1.4
 NEFA, μEq/L 613 ± 202
 IRI, μg/dl 8.7 ± 7.0
 HOMA-R 2.9 ± 2.7
 hsCRP, mg/dl 0.190 ± 0.357
 NT-proBNP, pg/ml 36.2 ± 55.3
 CPR, mg/dl 2.8 ± 9.6
Fat areas determined by CT scan  
 Total adipose tissue/BSA, cm2/m2 169.4 ± 74.9
 Visceral adipose tissue/BSA, cm2/m2 68.3 ± 30.6
 Subcutaneous adipose tissue/BSA, cm2/m2 101.1 ± 54.3
  1. eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; F-LDL, low-density lipoprotein calculated by Friedewald; NEFA, non-esterified fatty acid; IRI, immunoreactive insulin; HOMA, homeostasis model assessment; hsCRP, high-sensitivity C reactive protein; NT-pro BNP, N-terminal pro b-type natriuretic peptide; CPR, C-peptide immunoreactivity; CT, computed tomography; BSA, body surface area.